Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Cooper

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 4, 2009
Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufageninJiang Tian, Amjad Shidyak, Sankaridrug M Periyasamy, et al.
Kidney Medicine|February 3, 2025
Incident Heart Failure in Atherosclerotic Renal Artery Stenosis: A Post Hoc Analysis of the CORAL TrialRajesh Gupta, Michelle M Estrella, Rebecca Scherzer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 13, 2021
Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies ConferenceCaitlin W Hicks, Timothy W I Clark, Christopher J Cooper, et al.
Journal of the American Heart Association|March 24, 2020
Renal Fibrosis Is Significantly Attenuated Following Targeted Disruption of <i>Cd40</i> in Experimental Renal IschemiaShungang Zhang, Joshua D Breidenbach, Fatimah K Khalaf, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2014
Use of renin-angiotensin inhibitors in people with renal artery stenosisKaleigh L Evans, Katherine R Tuttle, David A Folt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 27, 2016
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL TrialKatherine R Tuttle, Lance D Dworkin, William Henrich, et al.
American Journal of Physiology. Renal Physiology|November 23, 2007
Partial nephrectomy as a model for uremic cardiomyopathy in the mouseDavid J Kennedy, Jihad Elkareh, Amjad Shidyak, et al.
International Journal of Nephrology and Renovascular Disease|April 10, 2019
Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) studyTian Chen, Pamela Brewster, Katherine R Tuttle, et al.
Plos One|March 18, 2017
Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosisChristopher A Drummond, Pamela S Brewster, Wencan He, et al.
Kidney International|October 4, 2016
Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressureSteven T Haller, Sivarajan Kumarasamy, David A Folt, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Hypertension (Dallas, Tex. : 1979)|November 4, 2009
Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufageninJiang Tian, Amjad Shidyak, Sankaridrug M Periyasamy, et al.
Kidney Medicine|February 3, 2025
Incident Heart Failure in Atherosclerotic Renal Artery Stenosis: A Post Hoc Analysis of the CORAL TrialRajesh Gupta, Michelle M Estrella, Rebecca Scherzer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 13, 2021
Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies ConferenceCaitlin W Hicks, Timothy W I Clark, Christopher J Cooper, et al.
Journal of the American Heart Association|March 24, 2020
Renal Fibrosis Is Significantly Attenuated Following Targeted Disruption of <i>Cd40</i> in Experimental Renal IschemiaShungang Zhang, Joshua D Breidenbach, Fatimah K Khalaf, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2014
Use of renin-angiotensin inhibitors in people with renal artery stenosisKaleigh L Evans, Katherine R Tuttle, David A Folt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 27, 2016
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL TrialKatherine R Tuttle, Lance D Dworkin, William Henrich, et al.
American Journal of Physiology. Renal Physiology|November 23, 2007
Partial nephrectomy as a model for uremic cardiomyopathy in the mouseDavid J Kennedy, Jihad Elkareh, Amjad Shidyak, et al.
International Journal of Nephrology and Renovascular Disease|April 10, 2019
Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) studyTian Chen, Pamela Brewster, Katherine R Tuttle, et al.
Plos One|March 18, 2017
Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosisChristopher A Drummond, Pamela S Brewster, Wencan He, et al.
Kidney International|October 4, 2016
Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressureSteven T Haller, Sivarajan Kumarasamy, David A Folt, et al.
Pageof 9